Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Qui‐Lim Choo, George C. Kuo, Amy J. Weiner, Lacy R. Overby, Daniel W. Bradley, Michael Houghton
Science · 1989 · 6,983 citations
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Choo, Q., Kuo, G. C., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989). Isolation of a cDNA cLone derived from a blood-borne Non-A, Non-B viral hepatitis genome. Science, 244(4902), 359–362. https://doi.org/10.1126/science.2523562
In text: (Choo et al., 1989)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
A random-primed complementary DNA library was constructed from plasma containing the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH. A complementary DNA clone was isolated that was shown to encode an antigen associated specifically with NANBH infections. This clone is not derived from host DNA but from an RNA molecule present in NANBH infections that consists of at least 10,000 nucleotides and that is positive-stranded with respect to the encoded NANBH antigen. These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae. This molecular approach should be of great value in the isolation and characterization of other unidentified infectious agents.
Related papers
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection2002
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡2006
- The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets2014
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C2003
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance2018
Metadata from OpenAlex (CC0). Citations are generated from the published record.